Fig. 3

Cell cycle phases (a at G1, b at G2 & c the S phase) and analysis by flow cytometry with location of miRs (200c, 221,346 and 1195) after treatments (d) with miRs and (e) with N-miRs in addition to the control without any miR and non-treated control cells